Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-2-7
pubmed:abstractText
Previous studies have demonstrated that mice lacking a functional folate binding protein 2 gene (Folbp2-/-) were significantly more sensitive to in utero arsenic exposure than were the wild-type mice similarly exposed. When these mice were fed a folate-deficient diet, the embryotoxic effect of arsenate was further exacerbated. Contrary to expectations, studies on 24-h urinary speciation of sodium arsenate did not demonstrate any significant difference in arsenic biotransformation between Folbp2-/- and Folbp2+/+ mice. To better understand the influence of folate pathway genes on arsenic embryotoxicity, the present investigation utilized transgenic mice with disrupted folate binding protein 1 (Folbp1) and reduced folate carrier (RFC) genes. Because complete inactivation of Folbp1 and RFC genes results in embryonic lethality, we used heterozygous animals. Overall, no RFC genotype-related differences in embryonic susceptibility to arsenic exposure were observed. Embryonic lethality and neural tube defect (NTD) frequency in Folbp1 mice was dose-dependent and differed from the RFC mice; however, no genotype-related differences were observed. The RFC heterozygotes tended to have higher plasma levels of S-adenosylhomocysteine (SAH) than did the wild-type controls, although this effect was not robust. It is concluded that genetic modifications at the Folbp1 and RFC loci confers no particular sensitivity to arsenic toxicity compared to wild-type controls, thus disproving the working hypothesis that decreased methylating capacity of the genetically modified mice would put them at increased risk for arsenic-induced reproductive toxicity.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0041-008X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
203
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
18-26
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15694460-Animals, pubmed-meshheading:15694460-Arsenates, pubmed-meshheading:15694460-Biological Transport, pubmed-meshheading:15694460-Carrier Proteins, pubmed-meshheading:15694460-Chimera, pubmed-meshheading:15694460-Female, pubmed-meshheading:15694460-Folate Receptors, GPI-Anchored, pubmed-meshheading:15694460-Folic Acid, pubmed-meshheading:15694460-Folic Acid Deficiency, pubmed-meshheading:15694460-Genotype, pubmed-meshheading:15694460-Male, pubmed-meshheading:15694460-Membrane Transport Proteins, pubmed-meshheading:15694460-Mice, pubmed-meshheading:15694460-Mice, Inbred C57BL, pubmed-meshheading:15694460-Mice, Knockout, pubmed-meshheading:15694460-No-Observed-Adverse-Effect Level, pubmed-meshheading:15694460-Receptors, Cell Surface, pubmed-meshheading:15694460-Reduced Folate Carrier Protein, pubmed-meshheading:15694460-Reproduction
pubmed:year
2005
pubmed:articleTitle
Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies.
pubmed:affiliation
Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.